AN IMMUNIFLUORESCENCE ASSAY FOR COMPLEMENT ACTIVATION BY THE CLASSICAL PATHWAYLINDER E; RHEN M; MERI S et al.1981; J. IMMUNOL. METHODS.; ISSN 0022-1759; NLD; DA. 1981; VOL. 47; NO 1; PP. 49-59; BIBL. 21 REF.Article

THE HUMAN COMPLEMENT SYSTEM: ASSEMBLY OF THE CLASSICAL PATHWAY C3 CONVERTASEKERR MA.1980; BIOCHEM. J.; GBR; DA. 1980; VOL. 189; NO 1; PP. 173-181; BIBL. 20 REF.Article

TRINITROPHENYLATED RED CELLS (E-TNP) AS A MODEL FOR ANTIBODY-INDEPENDENT ACTIVATION OF THE COMPLEMENT SYSTEM VIA THE CALSSICAL PATHWAY.LOOS M; THESEN R.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 1; PP. 24-28; BIBL. 22 REF.Article

CLASSICAL PATHWAY ACTIVATION OF COMPLEMENT SYSTEM BY IGA ANTI-C3 ANTIBODY = ACTIVATION PAR LA VOIE CLASSIQUE DU SYSTEME DE COMPLEMENT PAR L'ANTICORPS IGA ANTI-C3WILLIAMS BD; SLANEY JM; PRICE JF et al.1976; NATURE; G.B.; DA. 1976; VOL. 259; NO 5538; PP. 52-53; BIBL. 7 REF.Article

COMPLEMENT.MULLER EBERHARD HJ.1975; ANNU. REV. BIOCHEM.; U.S.A.; DA. 1975; VOL. 44; PP. 697-724; BIBL. 3 P.Article

ASPECTS FONDAMENTAUX ET MECANISMES D'ACTIVATION DU COMPLEMENT.ETIEVANT M.1978; REV. FR. MAL. RESP.; FR.; DA. 1978; VOL. 6; NO 1; PP. 5-9; ABS. ANGL.; BIBL. 2 REF.Article

ACTIVATION OF HUMAN COMPLEMENT BY GLUTARALDEHYDE-TREATED RED CELLS.HUGHES JONES NC; GARDNER B; ROWLANDS J et al.1977; NATURE; G.B.; DA. 1977; VOL. 270; NO 5638; PP. 613-614; BIBL. 20 REF.Article

CHARACTERISTICS OF COMPLEMENT CONSUMPTION BY ATOPIC ALLERGENSBERRENS L; VAN RIJSWIJK VERBEEK J; GUIKERS CLH et al.1976; IMMUNOCHEMISTRY; G.B.; DA. 1976; VOL. 13; NO 5; PP. 367-372; BIBL. 31 REF.Article

ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY BY NEPHRITIC FACTOR BOUND TO THE ALTERNATIVE PATHWAY C3/C5 CONVERTASESOBEL AT; COOPER NR; SCHREIBER RD et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 1; PP. 34-38; BIBL. 30 REF.Article

CLEAVAGE OF C2 BY C1S INTO THE ANTIGENICALLY DISTINCT FRAGMENTS C2A AND C2B: DEMONSTRATION OF BINDING OF C2B TO C4B.NAGASAWA S; STROUD RM.1977; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1977; VOL. 74; NO 7; PP. 2998-3001; BIBL. 16 REF.Article

MECHANISMS OF ACTIVATION OF COMPLEMENT BY EXTRACTS OF ASPERGILLUS FUMIGATUSDE BRACCO MM DE E; BUDZKO DB; NEGRONI R et al.1976; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1976; VOL. 5; NO 3; PP. 333-339; BIBL. 24 REF.Article

ACTIVATION OF THE COMPLEMENT SYSTEMCOOPER NR.1973; CONTEMPOR. TOPICS MOLEC. IMMUNOL.; G.B.; DA. 1973; VOL. 2; PP. 155-183; BIBL. 3P.Article

INHIBITION OF THE CLASSICAL COMPLEMENT PATHWAY BY SYNTHETIC PEPTIDES FROM THE SECOND CONSTANT DOMAIN OF THE HEAVY CHAIN OF HUMAN IMMUNOGLOBULIN GPRYSTOWSKY MB; KEHOE JM; ERICKSON BW et al.1981; BIOCHEMISTRY; ISSN 0006-2960; USA; DA. 1981; VOL. 20; NO 22; PP. 6349-6356; BIBL. 49 REF.Article

THE RELATIONSHIP BETWEEN THE BINDING ABILITY AND THE RATE OF ACTIVATION OF THE COMPLEMENT COMPONENT C1FOLKERD EJ; GARDNER B; HUGHES JONES NC et al.1980; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1980; VOL. 41; NO 1; PP. 179-185; BIBL. 29 REF.Article

INFLUENCE OF THE ALTERNATE COMPLEMENT PATHWAY ON OPSONIZATION OF SEVERAL BACTERIAL SPECIESFORSGREN A; QUIE PG.1974; INFECT. AND IMMUN.; U.S.A.; DA. 1974; VOL. 10; NO 2; PP. 402-404; BIBL. 7REF.Article

THE C5B-9 COMPLEX: SUBUNIT COMPOSITION OF THE CLASSICAL AND ALTERNATIVE PATHWAY-GENERATED COMPLEX.PODACK ER; KOLB WP; MULLER EBERHARD HJ et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 116; NO 5; PP. 1431-1435; BIBL. 8 REF.Article

LES VOIES D'ACTIVATION DU SYSTEME COMPLEMENT.BRINGUIER JP.1976; LYON PHARM.; FR.; DA. 1976; VOL. 27; NO 6; PP. 553-565; ABS. ANGL.; BIBL. 5 P.Article

REQUIREMENTS FOR THE SOLUBILIZATION OF IMMUNE AGGREGATES BY COMPLEMENT. THE ROLE OF THE CLASSICAL PATHWAY.TAKAHASHI M; TAKAHASHI S; BRADE V et al.1978; J. CLIN. INVEST.; USA; DA. 1978; VOL. 62; NO 2; PP. 349-358; BIBL. 37 REF.Article

COMPLEMENT RECEPTOR IS AN INHIBITOR OF THE COMPLEMENT CASCADEIIDA K; NUSSENZWEIG V.1981; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1981; VOL. 153; NO 5; PP. 1138-1150; BIBL. 46 REF.Article

THE ROLE OF COMPLEMENT IN VIRAL INFECTIONS. III: ACTIVATION OF THE CLASSICAL AND ALTERNATIVE COMPLEMENT PATHWAYS BY SINDBIS VIRUSHIRSCH RL; WINKELSTEIN JA; GRIFFIN DE et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 124; NO 5; PP. 2507-2510; BIBL. 19 REF.Article

POSSIBLE MECHANISMS OF THE FIRST STEP OF THE CLASSICAL COMPLEMENT ACTIVATION PATHWAY: BINDING AND ACTIVATION OF CLFUST G; MEDGYESI GA; RAJNAVOLGYI E et al.1978; IMMUNOLOGY; GBR; DA. 1978; VOL. 35; NO 6; PP. 873-884; BIBL. 27 REF.Article

THE MECHANISM OF ACTIVATION OF THE FIRST COMPONENT OF COMPLEMENT BY A UNIVALENT HAPTEN-IGG ANTIBODY COMPLEX.GOERS JW; ZICCARDI RJ; SCHUMAKER VN et al.1977; J. IMMUNOL.; G.B.; DA. 1977; VOL. 118; NO 6; PP. 2182-2191; BIBL. 33 REF.Article

DEVIATED LYSIS: TRANSFER OF COMPLEMENT LYTIC ACTIVITY TO UNSENSITIZED CELLS. II. GENERATION OF THE ACTIVITY BY INULIN AND BY ANTIGEN ANTIBODY COMPLEXES.ROTHER U; HANSCH G; ROTHER K et al.1976; Z. IMMUN.-FORSCH.; DTSCH.; DA. 1976; VOL. 151; NO 5; PP. 442-454; BIBL. 14 REF.Article

SCREENING FOR DEFICIENCIES IN THE CLASSICAL AND ALTERNATIVE PATHWAYS OF COMPLEMENT BY HEMOLYSIS IN GELTRUEDSSON L; SJOHOLM AG; LAURELL AB et al.1981; ACTA PATHOL. MICROBIOL. SCAND., SECT. C; ISSN 0304-1328; DNK; DA. 1981; VOL. 89; NO 3; PP. 161-166; BIBL. 25 REF.Article

KINETIC ANALYSIS OF CHEMOTACTIC FACTOR GENERATION IN HUMAN SERUM VIA ACTIVATION OF THE CLASSICAL AND ALTERNATE COMPLEMENT PATHWAYSGALLIN JI; CLARK RA; FRANK MM et al.1975; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1975; VOL. 3; NO 3; PP. 334-346; BIBL. 23REF.Article